Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PLXP

PLx Pharma (PLXP) Stock Price, News & Analysis

PLx Pharma logo

About PLx Pharma Stock (NASDAQ:PLXP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
12.96 million shs
Market Capitalization
$603 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PLx Pharma and its competitors with MarketBeat's FREE daily newsletter.

PLXP Stock News Headlines

Bitcoin just humbled Jeff Bezos
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
PLXp/USD - Pullix US Dollar
Protalix Biotherapeutics Inc (PLX)
Vertex Pharmaceuticals Inc VRTX
Vietnam National Petroleum Group (PLX)
PLx Pharma Inc (PLXPQ)
See More Headlines

PLXP Stock Analysis - Frequently Asked Questions

PLx Pharma Inc. (NASDAQ:PLXP) issued its quarterly earnings data on Friday, November, 12th. The biotechnology company reported ($0.37) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.09. The business's revenue for the quarter was up 560.0% compared to the same quarter last year.

PLx Pharma (PLXP) raised $68 million in an initial public offering (IPO) on Thursday, February 4th 2016. The company issued 3,800,000 shares at a price of $17.00-$19.00 per share. Raymond James served as the underwriter for the IPO and Maxim Group LLC and Janney Montgomery Scott were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that PLx Pharma investors own include Sorrento Therapeutics (SRNE), Ford Motor (F), SCYNEXIS (SCYX), CymaBay Therapeutics (CBAY), Energy Transfer (ET), Meta Platforms (META) and Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
7/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PLXP
CIK
1497504
Employees
16
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
($1.85)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$46.13 million
Net Margins
-606.91%
Pretax Margin
-606.91%
Return on Equity
-291.11%
Return on Assets
-119.43%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.79
Quick Ratio
4.28

Sales & Book Value

Annual Sales
$4.54 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.30 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,138,000
Free Float
26,530,000
Market Cap
$603 thousand
Optionable
Not Optionable
Beta
3.79

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:PLXP) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners